AI in Prior Authorization: A Mixed Prognosis

Verdict

Artificial intelligence offers a tantalizing promise to streamline the notoriously frustrating prior authorization process in healthcare. Theoretically, AI's ability to rapidly sift through vast amounts of data could expedite approvals for clear-cut medical claims, cutting down on delays and administrative overhead. However, based on early implementations and widespread concerns from medical professionals and patient advocates, the current trajectory suggests AI could, at best, be a mixed bag, and at worst, amplify existing issues, leading to more wrongful denials and worsening patient care. The consensus points towards a significant risk that AI, without proper oversight and a patient-centric design, will primarily serve to automate and accelerate a flawed system, potentially creating an "arms race to deny faster" rather than ensuring appropriate care.

The “Product”: AI-Driven Prior Authorization

Prior authorization is a long-standing requirement by health insurers for pre-approval of certain medical services, medications, or procedures recommended by physicians. Its stated purpose is to prevent overuse and control costs by ensuring medical necessity and exploring less expensive alternatives. In practice, it's often a source of significant burden, causing care delays, treatment abandonment, and worsened patient health. The "product" under review here is the integration of AI tools into this process, with the aim of either fixing or exacerbating these inherent problems.

Key Details & Functionality

At its core, AI is proposed to tackle the immense data processing demands of prior authorization. By leveraging machine learning, AI systems can efficiently analyze patient information, medical guidelines, and policy rules to make coverage determinations. The hope is that this automation will reduce the need for manual review for unambiguously allowable claims, thereby speeding up the process for patients and providers.

A notable government initiative is the WISeR (Wasteful and Inappropriate Service Reduction Model), launched by the Centers for Medicare and Medicaid Services (CMS). This demonstration project, currently running through December 2031 in six states, specifically targets waste and fraud in original Medicare. WISeR combines machine learning with human clinical review to evaluate services deemed vulnerable to overuse or abuse, such as certain skin and tissue substitutes, nerve stimulator implants, and knee arthroscopy for osteoarthritis. This marks a significant shift, as prior authorization has historically been less common in original Medicare compared to Medicare Advantage plans.

Recent policy changes also highlight the ongoing efforts to reform prior authorization. A 2024 rule under the Biden administration mandated insurers in the public sector to make urgent decisions within 72 hours and non-urgent ones within seven calendar days. The Trump administration also pledged with insurers to streamline processes, aiming for standardized electronic requests by 2027 and a reduction in the volume of services requiring prior authorization by 2026, including common procedures like colonoscopies and cataract surgeries.

User Experience: Impact on Stakeholders

The implementation of AI in prior authorization profoundly impacts patients, physicians, and even the insurers themselves.

For Patients

For patients, the current prior authorization system is already a major burden, leading to what NBC News described as "purgatory" where individuals run out of time or treatment options. A 2025 Commonwealth Fund survey revealed that one in five working-age adults with private insurance faced denials, leading to care delays for 41% and worsened health for over a quarter. The concern with AI is that it could accelerate wrongful denials, making it even harder for patients to access medically necessary care. While appeals processes exist, they are often complicated and time-consuming, though Medicare Advantage plans notably overturned 81% of denials upon appeal in 2024.

For Physicians

Physicians overwhelmingly express concerns. A 2025 American Medical Association (AMA) survey found that 61% of doctors feared AI would exacerbate denials of necessary treatments. They advocate for insurers to provide detailed clinical reasoning for denials and demand greater transparency regarding AI algorithms. Healthcare policy analyst Camm Epstein succinctly put it: "AI should be used to make appropriate care easier to approve, not necessary care easier to deny." The administrative burden on healthcare providers also remains a significant issue, with additional work required to deal with denials, even with automated processes.

For Insurers & Government

From the perspective of insurers and the government, AI is seen as a tool to enhance efficiency and curb unnecessary spending. CMS, for instance, states the WISeR model aims to "ensure timely and appropriate Medicare payment." However, a critical conflict of interest arises: vendors hired for WISeR earn revenue based on "averted expenditures," essentially profiting from rejecting care requests. This raises long-standing concerns about profit motives discouraging medically necessary care. The Trump administration's approach has been somewhat contradictory, expanding AI use in original Medicare while simultaneously pushing private insurers, including Medicare Advantage plans, to ease their prior authorization burdens.

Pros and Cons

Pros:

• Theoretical Efficiency: AI has the potential to quickly process straightforward claims, reducing review times and administrative bottlenecks.
• Fraud and Waste Reduction: Programs like WISeR aim to identify and reduce wasteful or fraudulent procedures, potentially saving healthcare costs.
• Streamlined Processes: With proper implementation, AI could standardize and simplify the overall prior authorization workflow.

Cons:

• Increased Wrongful Denials: A major concern among physicians is that AI will be used to deny more necessary treatments, rather than approve appropriate ones.
• Lack of Transparency: Opaque AI algorithms make it difficult to understand the rationale behind denials, hindering appeals and physician oversight.
• Profit Incentives for Denial: The model of compensating vendors based on "averted expenditures" creates a direct financial incentive to deny claims, regardless of medical necessity.
• Care Delays and Worsened Health: If AI increases denials or complicates the appeal process, patients could face longer waits, delayed treatment, and deteriorating health conditions.
• Administrative Burden: Despite automation, providers may still face a significant workload dealing with appeals and contesting AI-driven denials.
• Automation of a Broken System: Critics argue that AI is currently being used to automate an already flawed system, rather than fundamentally improving patient access to care.

Recommendation

For AI in prior authorization to truly be a fix rather than a further problem, a radical shift in implementation strategy is required. Simply automating existing, often problematic, decision-making processes, especially when tied to profit incentives for denials, is a recipe for exacerbating patient harm and physician frustration. The current pilot programs and industry pledges offer a glimpse of potential efficiency, but the overwhelming concerns regarding patient access and the transparency of decision-making cannot be ignored.

The clear recommendation is to proceed with extreme caution and implement robust safeguards. This means prioritizing patient outcomes above cost savings, mandating absolute transparency in AI algorithms, and ensuring that human clinical review remains the ultimate arbiter, especially for denials. Any system where vendors profit from denials creates an inherent conflict of interest that must be eliminated. Until AI tools are proven to consistently facilitate appropriate care approvals with full transparency and without adverse financial incentives, their widespread adoption risks making the already tortuous prior authorization process worse for those who need care most.

FAQ

Q: Will AI completely replace human decision-making in prior authorization?

A: While AI can automate parts of the review process, especially for clear-cut cases, there are strong calls from medical professionals and policies, including recent statements from insurers, that AI or algorithms without clinician review should not be used to deny requests involving medical necessity or clinical considerations. Human oversight and review are deemed essential, particularly for complex or denied claims.

Q: What are the main benefits AI is supposed to bring to prior authorization?

A: The primary theoretical benefits are the expedited approval of unambiguously allowable claims by efficiently sorting through vast amounts of information, thereby reducing care delays, and helping to identify and reduce wasteful or fraudulent medical spending.

Q: Why are doctors so concerned about AI in prior authorization?

A: Doctors are concerned that AI, as currently implemented or envisioned by some, will lead to an increase in wrongful denials of medically necessary treatments. They also worry about the lack of transparency in AI algorithms, the potential for care delays, and the significant administrative burden involved in appealing AI-driven denials, which they fear could worsen patient outcomes.